Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats. 
Home
Equities
MYGN
Chart

Myriad Genetics Inc

MYGN

Jan 1 1970 00:00:00
6.90
▲0.5300▲8.33%
6.42
7.05
6.34
6.37
126.36k
-1.12
-6.16
635.56M
92.18M
Chart
Fundamentals
Soon
Sentiment
Soon
Options
Loading...

Recent Filings

2024-10-10
Form 4
ID: 0001517026-24-000006
2024-10-10
Form 4
ID: 0001922964-24-000008
2024-10-10
Form 4
ID: 0001843872-24-000004
2024-10-09
Form 8-K
ID: 0000899923-24-000048
2024-09-23
Form 4
ID: 0001517026-24-000004
2024-09-23
Form 4
ID: 0001843568-24-000006
2024-09-23
Form 4
ID: 0001932320-24-000008
2024-09-16
Form 144
ID: 0002002698-24-000419
2024-09-12
Form 4
ID: 0001628280-24-040232
2024-09-12
Form 4
ID: 0001922964-24-000006

You might find these companies interesting

CLDX
Celldex Therapeutics, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
QDEL
Quidelortho Corp
In Vitro & In Vivo Diagnostic Substances (2835)
AWH
Aspira Women's Health Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
LNTH
Lantheus Holdings, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
CDIO
Cardio Diagnostics Holdings, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
TKNO
Alpha Teknova, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
VNRX
Volitionrx Ltd
In Vitro & In Vivo Diagnostic Substances (2835)
IDXX
Idexx Laboratories Inc /De
In Vitro & In Vivo Diagnostic Substances (2835)
TRIB
Trinity Biotech Plc
In Vitro & In Vivo Diagnostic Substances (2835)
ICCC
Immucell Corp /De/
In Vitro & In Vivo Diagnostic Substances (2835)
NTLA
Intellia Therapeutics, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
MYMD
Mymd Pharmaceuticals, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)
RLFTY
Relief Therapeutics Holding Sa
Pharmaceutical Preparations (2834)
SCPS
Scopus Biopharma Inc.
Pharmaceutical Preparations (2834)